Related Experiment Video
Updated: Oct 10, 2025
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
COVID-19-Associated Pulmonary Aspergillosis in the Critical Care Setting
1Jennifer M. Livermore is Advanced Practice Registered Nurse in Infectious Disease, CHI St Elizabeth, 555 South 70th St, Lincoln, NE 68506 (jennifer.livermore@bryanhealthcollege.edu).
Abstract:
The first confirmed case of COVID-19 in the United States was reported on January 20, 2020. Most infected individuals experience a mild illness with loss of taste and smell, body aches, fatigue, cough, and fever. However, about 5% of patients become critically ill and experience more serious symptoms such as respiratory distress, pulmonary emboli, or even multisystem organ failure. Those who become critically ill with COVID-19 are at high risk for superinfections, including pulmonary, bloodstream, and urinary tract infections. Invasive aspergillosis is emerging as a serious secondary pulmonary infection in patients with COVID-19 who experience respiratory distress syndrome. If these patients are not accurately diagnosed and subsequently treated, the infection can be fatal. This case study describes COVID-19-associated pulmonary aspergillosis in the critically ill patient.
Insights
Critically ill COVID-19 patients face a high risk of secondary infections like invasive pulmonary aspergillosis. Early diagnosis and treatment are crucial for survival in these severe cases.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- The first COVID-19 case in the US was reported January 20, 2020.
- While most COVID-19 cases are mild, approximately 5% develop critical illness, including respiratory distress and organ failure.
- Critically ill COVID-19 patients are susceptible to secondary infections, with invasive pulmonary aspergillosis emerging as a significant threat.
Purpose of the Study:
- To describe a case of COVID-19-associated pulmonary aspergillosis in a critically ill patient.
- To highlight the diagnostic and treatment challenges of this co-infection.
Main Methods:
- Case study presentation.
- Review of clinical data for a critically ill COVID-19 patient with suspected secondary pulmonary infection.
Main Results:
- The case study details the occurrence of invasive pulmonary aspergillosis in a critically ill patient with COVID-19 and respiratory distress syndrome.
- This co-infection poses a fatal risk if not promptly identified and managed.
Conclusions:
- COVID-19-associated pulmonary aspergillosis is a life-threatening complication in critically ill patients.
- Accurate and timely diagnosis, followed by appropriate treatment, is essential for improving outcomes.
More Related Videos
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:30Acute Respiratory Failure-III
01:21Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: